Amsterdam Court Gives no Substantive Ruling in Pharmaceutical Accountability Foundation-AbbVie Excessive Pricing Case on Humira
AMSTERDAM, 9 July 2025: The Amsterdam District Court declared the Pharmaceutical Accountability Foundation (PAF) inadmissible in its court case against AbbVie, and has thus not engaged with substantive merits of the...